摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[4-(2-溴乙氧基)苯基]-(4-氯苯基)甲酮 | 160412-57-7

中文名称
[4-(2-溴乙氧基)苯基]-(4-氯苯基)甲酮
中文别名
——
英文名称
[4-(2-bromoethoxy)phenyl]-(4-chlorophenyl)methanone
英文别名
[4-(2-Bromoethoxy)phenyl](4-chlorophenyl)methanone
[4-(2-溴乙氧基)苯基]-(4-氯苯基)甲酮化学式
CAS
160412-57-7
化学式
C15H12BrClO2
mdl
——
分子量
339.616
InChiKey
CZXRYFFVWIJQJQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    450.0±40.0 °C(Predicted)
  • 密度:
    1.456±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [4-(2-溴乙氧基)苯基]-(4-氯苯基)甲酮对甲苯磺酸 作用下, 生成 1-(2-bromoethoxy)-4-[(Z)-1-(4-chlorophenyl)-2-phenylethenyl]benzene
    参考文献:
    名称:
    Z-1,1-二氯-2-[4-(2-二甲氨基乙氧基)苯基]-2-(4-羟基苯基)-3-苯基环丙烷和Z-1,1-二氯-2-[4-( 2-二甲氨基乙氧基)苯基]-2-(4-氯苯基)-3-苯基环丙烷
    摘要:
    描述了标题化合物的合成。合成的关键步骤是纯Z-乙烯的制备、二氯卡宾的立体定向加成、苯酚的氨基脱卤和脱保护。七氟甲苯基保护基团用于合成在碱性异相环丙烷化反应条件下稳定的纯 Z-乙烯。
    DOI:
    10.1246/cl.1994.1821
  • 作为产物:
    描述:
    4-氯-4'-羟基二苯甲酮1,2-二溴乙烷potassium carbonate 作用下, 以 丙酮 为溶剂, 以75%的产率得到[4-(2-溴乙氧基)苯基]-(4-氯苯基)甲酮
    参考文献:
    名称:
    Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators
    摘要:
    The development of type 2 diabetes in obese individuals is linked to lipid accumulation in non-adipose tissues. A series of N-acetyl-L-tyrosine derivatives were synthesized and evaluated for PPAR transactivation. Compounds 4d and 4f were found to show better PPAR alpha transactivation as compared to PPAR gamma. Molecular docking analysis was carried out to study their important interactions with the active site of PPAR alpha. (c) 2006 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2006.11.005
点击查看最新优质反应信息

文献信息

  • Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARα/γ dual agonists
    作者:Rakesh Kumar、Uma Ramachandran、Smriti Khanna、Prasad V. Bharatam、Suryaprakash Raichur、Ranjan Chakrabarti
    DOI:10.1016/j.bmc.2006.06.063
    日期:2007.2.1
    A novel series of L-tyrosine derivatives have been reported with potential PPAR alpha/gamma dual agonistic activity. In vitro cell based PPAR alpha/gamma transactivation studies have shown compound 4a and compound 4f to be the most potent PPAR gamma and PPAR alpha activators, respectively. Molecular docking studies performed on these series of compounds have complemented the experimental results and have led to interesting inferences. (c) 2006 Elsevier Ltd. All rights reserved.
  • Singh Satendra, Magarian Robert A., Chem. Lett, (1994) N 10, S 1821-1824
    作者:Singh Satendra, Magarian Robert A.
    DOI:——
    日期:——
  • Clemastine/tamoxifen hybrids as easily accessible antileishmanial drug leads
    作者:V. S. Agostino、M. L. Buerdsell、S. R. B. Uliana、P. W. Denny、A. C. Coelho、P. G. Steel
    DOI:10.1039/d3ob02091f
    日期:2024.2.28

    Simple chimeric structures derived from clemastine and tamoxifen represent easily accessible lead compounds for new antileishmanial drug discovery.

  • Synthesis and evaluation of N-acetyl-l-tyrosine based compounds as PPARα selective activators
    作者:Rakesh Kumar、Uma Ramachandran、Suryaprakash Raichur、Ranjan Chakrabarti、Rahul Jain
    DOI:10.1016/j.ejmech.2006.11.005
    日期:2007.4
    The development of type 2 diabetes in obese individuals is linked to lipid accumulation in non-adipose tissues. A series of N-acetyl-L-tyrosine derivatives were synthesized and evaluated for PPAR transactivation. Compounds 4d and 4f were found to show better PPAR alpha transactivation as compared to PPAR gamma. Molecular docking analysis was carried out to study their important interactions with the active site of PPAR alpha. (c) 2006 Elsevier Masson SAS. All rights reserved.
  • Synthesis of Z-1,1-Dichloro-2-[4-(2-dimethylaminoethoxy)phenyl]-2-(4-hydroxyphenyl)-3-phenyl Cyclopropane and Z-1,1-Dichloro-2-[4-(2-dimethylaminoethoxy)phenyl]-2-(4-chlorophenyl)-3-phenyl Cyclopropane
    作者:Satendra Singh、Robert A. Magarian
    DOI:10.1246/cl.1994.1821
    日期:1994.10
    steps in the synthesis are the preparation of the pure Z-ethene, the stereospecific addition of dichlorocarbene, amino-dehalogenation and deprotection of the phenol. Heptafluorotolyl protecting group is used in the synthesis of pure Z-ethene which is stable under basic heterogenous cyclopropanation reaction conditions.
    描述了标题化合物的合成。合成的关键步骤是纯Z-乙烯的制备、二氯卡宾的立体定向加成、苯酚的氨基脱卤和脱保护。七氟甲苯基保护基团用于合成在碱性异相环丙烷化反应条件下稳定的纯 Z-乙烯。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐